Haleon (HLN) Total Current Liabilities (2021 - 2026)
Haleon's (HLN) quarterly Total Current Liabilities came in at -$8.4 billion in Q2 2026, down 26.75% on a QoQ basis from -$6.6 billion in Q4 2025.
Haleon (HLN) Total Current Liabilities (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Total Current Liabilities data on file, last reported at -$8.4 billion in Q2 2026.
- Quarterly Total Current Liabilities changed N/A year-over-year to -$8.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.4 billion (changed N/A YoY) and the FY2025 annual result came in at -$6.6 billion, down 188.32% from the prior year.
- Total Current Liabilities fell to -$8.4 billion in Q2 2026, from -$6.6 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $7.5 billion in Q4 2024 to a low of -$8.4 billion in Q2 2026.
- A 5-year average of -$1.9 billion and a median of -$5.8 billion in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities grew 29.53% — and 2025, when it tumbled 188.6%.
- Tracing HLN's Total Current Liabilities over 5 years: stood at $5.1 billion in 2022, then advanced by 12.35% to $5.8 billion in 2023, then gained by 29.53% to $7.5 billion in 2024, then slumped by 188.6% to -$6.6 billion in 2025, then retreated by 26.75% to -$8.4 billion in 2026.
- The last three Total Current Liabilities figures came in at -$8.4 billion (Q2 2026), -$6.6 billion (Q4 2025), and $7.5 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.79 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 662.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.38 Bn |
| Dec 31, 2025 | -6.61 Bn |
| Dec 31, 2024 | 7.46 Bn |
| Jun 30, 2024 | -7.10 Bn |
| Dec 31, 2023 | 5.76 Bn |
| Jun 30, 2023 | -6.24 Bn |
| Dec 31, 2022 | 5.13 Bn |
| Jun 30, 2022 | -5.29 Bn |
| Dec 31, 2021 | 5.71 Bn |